Majority of Hospitals Utilize Force Therapeutics for Compliance
Overview of Force Therapeutics Success Rate
The majority of hospitals utilizing Force Therapeutics' patient engagement platform are on track to comply with the CMS Total Hip and Knee Arthroplasty Patient-Reported Outcome - Performance Measure (THA/TKA PRO-PM). This compliance is crucial for avoiding significant financial penalties, estimated to reach millions.
Impact of Compliance on Financial Penalties
By meeting the requirements laid out by the Centers for Medicare & Medicaid Services (CMS), hospitals can mitigate a potential 25% reduction in the annual payment update for Medicare reimbursement. This is especially important as non-compliance can affect various claims, leading to detrimental financial implications for healthcare systems.
Encouraging Patient Engagement in Orthopedic Care
CMS introduced the THA/TKA PRO-PM to gauge improvements in pain and functionality post-surgery from a patient’s perspective. Given that THAs and TKAs are among the most frequently performed elective surgeries for Medicare beneficiaries, CMS aims to collect data that highlights inconsistencies and disparities in outcomes across practices. This data is essential for ensuring that the healthcare system operates efficiently and effectively.
The Importance of Patient-Reported Outcome Measures
To comply with CMS’s mandatory reporting requirements, it’s essential for hospitals to gather comprehensive patient-reported outcome measures (PROMs). This includes collecting data before surgery and following up one year after, which can be a considerable challenge for many hospitals.
Strategic Advantage Through Compliance
By actively using the Force Therapeutics platform, a notable success story emerges. One orthopedic chair in a large health system stated that they have effectively safeguarded their compliance with CMS regulations, which translates to substantial financial savings for their organization.
Innovative Ways to Enhance Patient Engagement
Force Therapeutics focuses on a comprehensive strategy that maximizes patient engagement throughout the surgical journey. Their approach includes pre-operative education, such as virtual joint classes, and extensive post-operative education, which promotes recovery and compliance with PROMs.
CEO Insights on Regulatory Changes
CEO Bronwyn Spira emphasizes that Force Therapeutics goes beyond ensuring compliance. They offer expert clinical guidance to clients, helping them adapt ahead of regulatory changes and reimbursement policies that influence their operations.
Key Features of Force Therapeutics Platform
Comprehensive Patient Education
Throughout their recovery journey, Force Therapeutics proactively engages patients. This approach helps improve survey completion rates and enhances overall patient satisfaction.
Engagement Through Gamification
The platform incorporates gamification by encouraging patients to set and meet treatment goals, rewarding them upon completion to enrich their recovery experience.
Automation for Efficiency
Innovative automation ensures patients receive timely forms and reminders, striking a balance between engagement and avoiding notification fatigue.
Streamlined EHR Integration
Force Therapeutics facilitates seamless reporting through its EHR-integrated PROMs, making submissions easier and more efficient, aligning well with CMS quality reporting standards.
Panel Discussions for Enhanced Insights
For further insights, users can access discussions featuring top-performing users of Force Therapeutics who share their experiences with THA/TKA PRO-PM. These conversations provide valuable information on best practices and strategies for compliance.
About Force Therapeutics
Force Therapeutics provides a comprehensive surgical episode of care management solution designed for patients undergoing specialized procedures. By boosting patient engagement and satisfaction through clinically validated remote care, Force Therapeutics enhances operational efficiency and reduces healthcare variation.
Frequently Asked Questions
What is the main goal of Force Therapeutics?
Force Therapeutics aims to improve patient engagement and satisfaction while ensuring compliance with CMS requirements.
How many hospitals use Force Therapeutics?
A significant 84% of hospitals using the platform are on track to meet CMS compliance standards.
What penalties might hospitals face for non-compliance?
Hospitals may incur a 25% reduction in annual Medicare payment updates if they fail to comply with the CMS reporting requirements.
What strategies does Force Therapeutics implement to enhance engagement?
The platform includes patient education, gamification, and automation to ensure ongoing patient participation throughout their recovery.
Who is the CEO of Force Therapeutics?
Bronwyn Spira serves as the CEO of Force Therapeutics, guiding the organization in navigating healthcare compliance and patient care challenges.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.